Company: SHPH
Filing Date: 2025-02-26
Form Type: 10-K
Source: 0001493152-25-008300
Chunk: 558

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-02-26
Form: 10-K
Item: Item 1C
Chunk 558
---
, CPA (Chair), Bette Jacobs and Chris H. Senanayake, assists our board of directors
in its oversight of the Company’s accounting and financial reporting processes and the audits of the Company’s financial
statements, including (a) the quality and integrity of the Company’s financial statements (b) the Company’s compliance with
legal and regulatory requirements, (c) the independent auditors’ qualifications and independence and (d) the performance of the
Company’s internal audit functions and independent auditors, as well as other matters which may come before it as directed by the
board of directors. Further, the audit committee, to the extent it deems necessary or appropriate, among its several other responsibilities,
will:

    ●
    be
    responsible for the appointment, compensation, retention, termination and oversight of the work of any independent auditor engaged
    for the purpose of preparing or issuing an audit report or performing other audit, review or attest services for the Company;

    ●
    discuss
    the annual audited financial statements and the quarterly unaudited financial statements with management and the independent auditor
    prior to their filing with the SEC in our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q;

    ●
    review
    with the Company’s management on a periodic basis (i) issues regarding accounting principles and financial statement presentations,
    including any significant changes in our Company’s selection or application of accounting principles; and (ii) the effect of
    any regulatory and accounting initiatives, as well as off-balance sheet structures, on the financial statements of the Company;

    ●
    monitor
    the Company’s policies for compliance with federal, state, local and foreign laws and regulations and the Company’s policies
    on corporate conduct;

    ●
    maintain
    open, continuing and direct communication between the board of directors, the audit committee and our independent auditors; and

    ●
    monitor
    our compliance with legal and regulatory requirements and will have the authority to initiate any special investigations of conflicts
    of interest, and compliance with federal, state and local laws and regulations, including the Foreign Corrupt Practices Act, as may
    be warranted.

Compensation
Committee

The
compensation committee, which consists of Steve Richards (Chair) and Joshua Schafer, aids our board of directors in meeting its responsibilities
relating to the compensation of the Company’s executive officers and to administer all incentive compensation plans and equity-based
plans of the